109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
Double-stranded RNA compounds to CASP2 and uses thereof
#5102Nucleic acid inducing RNA interference modified for preventing off-target, and use thereof
#5103METHODS FOR TREATMENT OF WOUND HEALING UTILIZING CHEMICALLY MODIFIED OLIGONUCLEOTIDES
#5104Immunotherapy of cancer
#5105Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
#5106Compositions of asymmetric interfering RNA and uses thereof
#5107SiRNA and their use in methods and compositions for inhibiting the expression of the FLAP gene
#5108Drug for Disease Caused by Expression of Periostin Except Eye Disease, and Use Thereof
#51093′end caps for RNAi agents for use in RNA interference
#5110Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
#5111Cationic lipid
#5112FORMULATIONS FOR INHIBITION OF pcsk9 FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
#5113MEANS FOR LUNG SPECIFIC DELIVERY
#5114Complement component iRNA compositions and methods of use thereof
#5115RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#5116COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MYLIP/IDOL GENE
#5117Pharmaceutical composition for treatment of radiation- or drug-resistant cancer comprising HRP-3 inhibitor
#5118Haplotype Based Generalizable Allele Specific Silencing for Therapy of Cardiovascular Disease
#5119IDENTIFICATION OF A NOVEL B CELL CYTOKINE
#5120Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y
#5121Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1
#5122METHOD FOR TRANSFORMATION OF STRAMENOPILE
#5123Compositions and methods for use in treating silicosis and lung cancer
#5124Small interference RNAs, uses thereof and method for inhibiting the expression of PLK1 gene
#5125Methods for identifying therapeutic targets and treating monitoring cancers
#5126Method of inhibiting macrophage activation using an inhibitor of PARP9
#5127Use of IKK epsilon inhibitors to activate NFAT and T cell response
#5128RNA-BASED HIV INHIBITORS
#5129Compositions and methods for inhibiting NF-κB and SOD-1 to treat amyotrophic lateral sclerosis
#5130Compositions and methods for treating cancer by rational targeting of protein translation
#5131Breast cancer biomarkers and methods of using same
#5132Methods and compositions for interference with DNA polymerase and DNA synthesis
#5133Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
#5134Quantification and spatio-temporal tracking of a target using a spherical nucleic acid (SNA)
#5135Molecular targets for selective eradication of senescent cells
#5136RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF
#5137MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#5138MAGNETIC INORGANIC IRON-BASED NANOPARTICLES
#5139Multi-arm biodegradable polymers for nucleic acid delivery
#5140TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#5141MODULATION OF AXON DEGENERATION
#5142Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3
#5143Organic compositions to treat beta-ENaC-related diseases
#5144Compositions and methods for inhibiting gene expression of factor XII
#5145PRODUCTS AND METHODS FOR TREATMENT OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS
#5146CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID MOLECULES THAT MEDIATE RNA INTERFERENCE
#5147METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF ASSEMBLE IN CELLS AND PRODUCE RNAI ACTIVITY
#5148Disulfide-containing alkyne linking agents
#5149RNA Interference Agents
#5150COMPOSITIONS AND METHODS FOR MODULATING AUTOPHAGIC CELL DEATH
#5151NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND USES THEREOF
#5152Dual Peptide-Mediated Targeted Delivery System
#5153Methods for treating hepatitis C virus infectious disease
#5154COMPOSITIONS AND METHODS RELATING TO C5L2
#5155RNA POLYMERASE I1 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#5156IMPROVED WOUND HEALING COMPOSITIONS AND TREATMENTS
#5157Dynamin 2 inhibitor for the treatment of centronuclear myopathies
#5158Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion
#5159Methods relating to circulating tumor cell clusters and the treatment of cancer
#5160Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus
#5161COMPOSITIONS AND METHODS FOR SILENCING EBOLA VIRUS GENE EXPRESSION
#5162MODIFIED iRNA AGENTS
#5163Compositions and methods for inhibiting expression of the LECT2 gene
#5164RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
#5165Compositions and Methods for Inhibiting Expression of Transthyretin
#5166CELL DIFFERENTIATION MARKER AND ITS USES
#5167MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#5168Compositions and methods for promoting the mineralization of biological tissue
#5169METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1
#5170Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT
#5171Method to trigger RNA interference
#5172RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS
#5173RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION
#5174POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS
#5175MCPIP protection against osteoclast production
#5176METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS
#5177Interfering RNA delivery system and uses thereof
#5178SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5179COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#5180Cationic lipid
#5181REGULATION OF NPVF GENE AND ITS PRODUCTS: A METHOD FOR MODULATING ENERGY IMBALANCE
#5182Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#5183Block copolymers and uses thereof
#5184Sterically stabilized cationic nanocarrier, kits and method of use
#5185Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury
#5186Mutant calreticulin for the diagnosis of myeloid malignancies
#5187Non-liposomal systems for nucleic acid delivery
#5188TRANSGENIC TREES HAVING REDUCED XYLAN CONTENT
#5189COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION
#5190Short hairpin RNA compositions, methods of making and applications thereof
#5191Poly(amine-co-ester) nanoparticles and methods of use thereof
#5192PIK3C2G fusions
#5193Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#5194Compositions and methods for inhibiting expression of the ALAS1 gene
#5195Reduced size self-delivering RNAI compounds
#5196Methods for predicting the progression and treating a chronic kidney disease in a patient
#5197Complement component C5 iRNA compositions and methods of use thereof
#5198Lipid particles with asymmetric cationic lipids for RNA delivery
#5199RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#5200Formats for organic compounds for use in RNA interference
#5201Serpina1 siRNAs: compositions of matter and methods of treatment
#5202Anti-PVRIG antibodies and methods of use
#5203Method of inhibiting activation of a T cell by administering an anti-RGM antibody or an RGM siRNA
#5204HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention
#5205Nucleic acid-lipopolymer compositions
#5206DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#5207RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders
#5208siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 gene
#5209Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
#5210ALLELE-SPECIFIC RNA SILENCING FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
#5211Compounds for inducing anti-tumor immunity and methods thereof
#5212Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing
#5213Methods for Treating and Preventing Multiple Sclerosis
#5214Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
#5215Technology for the Preparation of Microparticles
#5216Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#5217siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof
#5218RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF
#5219Non-enzymatic, salt-mediated synthesis of polynucleic acids
#5220Hypoxia-Targeted Delivery System for Pharmaceutical Agents
#5221Biological control of insects
#5222METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#5223Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests
#5224PARENTAL RNAI SUPPRESSION OF HUNCHBACK GENE TO CONTROL COLEOPTERAN PESTS
#5225Inhibition of ferrochelatase as an antiangiogenic therapy
#5226Anti-tumor therapy
#5227Compositions for targeted delivery of siRNA
#5228Single-stranded RNAi agents containing an internal, non-nucleic acid spacer
#5229ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORS
#5230Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
#5231Universal protein tag for double stranded nucleic acid delivery
#5232Cell-specific targeting using nanostructured delivery systems
#5233NOVEL LINCRNA AND INTERFERING NUCLEIC ACID MOLECULES, COMPOSITIONS AND METHODS AND USES THEREOF FOR REGULATING ANGIOGENESIS AND RELATED CONDITIONS
#5234Methods and compositions for ameliorating pancreatic cancer
#5235Kits for classifying a subject having or at risk for developing idiopathic scoliosis
#5236UNA OLIGOMER ACTIVE STRUCTURES FOR THERAPEUTIC AGENTS
#5237Notch 1 specific siRNA molecule
#5238RNAi for the control of phytopathogenic fungi and oomycetes by inhibiting the expression of CYP51 genes
#5239METHODS OF MODULATING LYMPHANGIOGENESIS, E.G., TO TREAT CORNEAL TRANSPLANT REJECTION, IN A SUBJECT
#5240Organic compounds to treat hepatitis B virus
#5241THERAPEUTIC COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47 AND P21
#5242Methods of modulating compliance of the trabecular meshwork
#5243Compositions and methods for treating lung disease and injury
#5244METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING METALLOTHIONEINS
#5245Ph-sensitive peptides and their nanoparticles for drug delivery
#5246Novel Delivery Compositions and Methods of Using Same
#5247Methods of diagnosing, classifying and treating endometrial cancer and precancer
#5248Use of RHOA in cancer diagnosis and inhibitor screening
#5249Genetic inhibition by double-stranded RNA
#5250Methods and means for treatment of osteoarthritis
#5251RNA interference agents for GST-PI gene modulation
#5252Liposome for topical administration and application thereof
#5253METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#5254RNA interference agents for P21 gene modulation
#5255RNA agents for P21 gene modulation
#5256RNA agents for GST-Pi gene modulation
#5257PARENTAL RNAI SUPPRESSION OF KRUPPEL GENE TO CONTROL COLEOPTERAN PESTS
#5258Parental RNAI suppression of hunchback gene to control hemipteran pests
#5259Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests
#5260Compositions and Methods for Inducing Senescence in Cancer Cells
#5261Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof
#5262METHODS OF USE OF SPHINGOLIPID POLYALKYLAMINE OLIGONUCLEOTIDE COMPOUNDS
#5263RNA/DNA nanoparticle for siRNA target-specific delivery and vehicle including the same
#5264Block copolymers
#5265METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS
#5266Hydrogels for delivery of therapeutic compounds
#5267Conjugated lipomers and uses thereof
#5268Tyrosine-based lipids for delivery of therapeutics
#5269Nanocomplexes for co-delivering a drug and siRNA and uses thereof
#5270Bruton's Tyrosine Kinase as Anti-Cancer Drug Target
#5271Method of treating pain with an antibody against netrin-4, Unc5B or neogenin
#5272Cytotoxic T cell response modifiers
#5273Methods and compositions for selecting siRNA of improved functionality
#5274EPIGENETIC REGULATORS OF FRATAXIN
#5275Antisense-based small RNA agents targeting the Gag open reading frame of HIV-1 RNA
#5276Methods and compositions for selecting siRNA of improved functionality
#5277SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure
#5278COMPOSITIONS AND METHODS FOR TREATING ANAPLASTIC THYROID CANCER
#5279Development of novel macromolecule transduction domain with improved cell permeability and method for using same
#5280Lipids and compositions for the delivery of therapeutics
#5281Biomolecular group related to cell anti-aging
#5282Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias
#5283Methods for treating ischemia-reperfusion injury
#5284Methods of treating thyroid eye disease
#5285NUCAMPHOLIN NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN INSECT PESTS
#5286Methods and compositions for selecting siRNA of improved functionality
#5287Compositions and methods for inhibiting expression of mutant EGFR gene
#5288Ligase E3 RNF185 inhibitors and uses thereof
#5289Methods of identifying and treating poor prognosis cancers
#5290SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOREGULATORY AGENTS
#5291DESIGN AND CONSTRUCTION OF BIFUNCTIONAL SHORT HAIRPIN RNA
#5292INHIBITING CANCER METASTASIS
#5293Methods for treating and/or limiting development of diabetes
#5294Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
#5295Targeting non-coding RNA for RNA interference
#5296Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
#5297Compositions and methods for inhibiting gene expressions
#5298Modulation of γδ T cells
#5299NEW CELL-SPECIFICALLY ACTIVE NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR THE APPLICATION THEREOF
#5300Novel linker, preparation method, and application thereof
#5301Antisense oligonucleotides with improved pharmacokinetic properties
#5302Methods for treating and/or limiting development of diabetes
#5303Methods and compositions for selecting siRNA of improved functionality
#5304RECOMBINANT CELLS AND METHODS OF USING SUCH CELLS TO IDENTIFY CIRCADIAN RHYTHM MODULATORS
#5305Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#5306Methods and compositions for treating malignant tumors associated with KRAS mutation
#5307RNA interference compositions and methods for malignant tumors
#5308Composition for reducing senescence of cell or subject comprising smurf2 inhibitor and use thereof
#5309Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#5310Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
#5311Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
#5312Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
#5313Compositions and methods for induced tissue regeneration in mammalian species
#5314Monoclonal anti-GT 468 antibodies for treatment of cancer
#5315COMPOSITIONS AND METHODS FOR TREATING BONE CONDITIONS
#5316METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#5317Treating alcohol-mediated disorders by inhibition of RGS6
#5318Protein engineered systems for delivery of molecules
#5319PEPTIDE-AND AMINE-MODIFIED GLUCAN PARTICLES FOR DELIVERY OF THERAPEUTIC CARGOES
#5320PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
#5321FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
#5322Fidgetin-like 2 as a target to enhance wound healing
#5323Organic small hairpin RNAs
#5324Compositions and methods for increasing erythropoietin (EPO) production
#5325Conserved HBV and HCV sequences useful for gene silencing
#5326Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
#5327MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#5328Compositions and methods using capsids resistant to hydrolases
#5329E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS
#5330Methods and materials for treating cancer
#5331MPS peptides and use thereof
#5332System for delivering therapeutic agents into living cells and cells nuclei
#5333Peptide sequence design and use thereof for peptide-mediated siRNA delivery
#5334Sphingolipid-polyalkylamine-oligonucleotide compounds
#5335AGENT FOR TREATING FIBROSIS OF THE INTESTINE
#5336Methods of treating pre-eclampsia or eclampsia
#5337METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY
#5338LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
#5339Delivery of therapeutic agent
#5340Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)
#5341UNA single stranded oligomers for therapeutics
#5342Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
#5343TRPM4 channel inhibitors for stroke treatment
#5344CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS
#5345Methods and compositions for treating and diagnosing diseases
#5346Modulation of axon degeneration
#5347Methods and compositions for treating autoimmune disorders by targeting Kv1.3 ion channels with functionalized lipid-derived nanovesicles
#5348Methods for suppressing adipocyte differentiation
#5349Polynucleotides for multivalent RNA interference, compositions and methods of use thereof
#5350METHODS OF TREATING CANCER AND PREVENTING CANCER DRUG RESISTANCE
#5351Compositions and methods for regulating gene expression via RNA interference
#5352Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
#5353Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses
#5354Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists
#5355Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus
#5356NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES
#5357Multi-tailed lipids and uses thereof
#5358Corneal endothelium ECM therapeutic medicaments
#5359Polyarginine-coated magnetic nanovector and methods of use thereof
#5360METHOD FOR CELL MEMBRANE PERMEATION FOR COMPOUND
#5361Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes
#5362Compositions and methods for controlled delivery of inhibitory ribonucleic acids
#5363Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor
#5364Method of regulating gene expression
#5365NOVEL COMPOUNDS
#5366Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#5367COMPOUND ADMINISTRATION PRECURSOR AND MEDICAMENT CARRIER PREPARATION
#5368METHOD FOR RECOMBINANT PROTEIN PRODUCTION IN MAMMALIAN CELLS
#5369Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
#5370Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
#5371Low density lipoprotein receptor-mediated siRNA delivery
#5372Compositions and methods for treating alzheimer's disease and other tauopathies
#5373Nucleic acid particles, methods and use thereof
#5374Methods and compositions involving lincRNA and leukemia
#5375TMPRSS6 iRNA compositions and methods of use thereof
#5376RNA interference-based therapeutic against anthrax
#5377Compositions and methods for inhibiting expression of TMPRSS6 gene
#5378LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
#5379METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES THAT ARE DIRECTED TO mRNA BINDING, AND ALSO NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR SUCH USE
#5380Dengue virus-specific siRNA, double helix oligo-RNA structure comprising siRNA, and composition for suppressing proliferation of dengue virus comprising RNA structure
#5381RNAi agent for inhibition of Chikungunya virus
#5382Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof
#5383Age-related macular degeneration treatment
#5384Compositions and methods for the delivery of nucleic acids
#5385Methods for expressing a polynucleotide of interest in the retina of a subject
#5386Method of treating intracellular infection
#5387Dosage compensating transgenes and cells
#5388COMPOSITIONS AND METHODS FOR MODULATING HIV ACTIVATION
#5389CHI3L1 FOR THE DETECTION AND TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
#5390Oncogene associated with human cancers and methods of use thereof
#5391RAGE AS A C1Q RECEPTOR, METHODS AND APPLICATIONS
#5392Compositions and methods for delivering nucleic acid to a cell
#5393Glucan-encapsulated siRNA for treating type 2 diabetes mellitus
#5394TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH DYSREGULATION OF MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1 (MTORC1)
#5395COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS
#5396Screening Method For Compound Having Obesity Preventive Or Therapeutic Activity
#5397Compositions and methods for treating cancer and other diseases
#5398Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5399Targeting ABCB5 for cancer therapy
#5400METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT